MSM Pharma SRL
2.8 FTEThe score of MSM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +13 % Headcount (avg FTE) +40 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MSM Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 121,699 € | ||||
| Equity | 230,323 € | ||||
| Cash | 126,267 € | ||||
| EBITDA | 267,062 € | ||||
| Total assets | 919,634 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 28 Jan 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 08 Feb 2024
- Year ended 30 Jun 2022filed on 05 Jun 2023
- Year ended 30 Jun 2021filed on 21 Mar 2022
MSM Pharma's financial analysis
- Solvency25.0%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MSM Pharma
MSM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.538.417
- VAT number
- BE0898538417
- Peppol
- Registered · 0208:0898538417 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jun 2008
- Registered office
- 1180 Uccle
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 28 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MSM Pharma (SRL) has been based in Uccle since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 121,699 € and equity of 230,323 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 25.0%, below the median of its sector (37.8%).
Companies similar to MSM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Brasseur L. Business and other management consultancy activities Wavre · balance sheet €1.05m
- CCW Consulting Business and other management consultancy activities Seraing · balance sheet 490,756 €
- PG Pharmaceuticals Business and other management consultancy activities Opwijk · balance sheet €1.86m
- Pavobur Retail sale of pharmaceutical products Vosselaar · balance sheet 943,141 €
- Apotheek Spriet Retail sale of pharmaceutical products Berlare · balance sheet 772,384 €
- Farmacie Henri Retail sale of pharmaceutical products Edegem · balance sheet 635,645 €
- Degrofarm Retail sale of pharmaceutical products Deinze · balance sheet €1.47m
- Omnicare Farma Dam Retail sale of pharmaceutical products Lokeren · balance sheet €1.25m
Frequently asked questions about MSM Pharma
What is the revenue of MSM Pharma?
MSM Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MSM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0898538417 for MSM Pharma, if the company is VAT-registered. Its company number (CBE) is 0898.538.417.
Where is the registered office of MSM Pharma?
According to the CBE register, the registered office of MSM Pharma is in 1180 Uccle.
What is the equity of MSM Pharma?
At the close of the 2025 financial year, the equity of MSM Pharma amounts to 230,323 €, a solvency of 25.0% of total assets.
How many people work at MSM Pharma?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages MSM Pharma?
The register lists 1 active mandates at MSM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MSM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →